Compare Shell PLC (SHEL) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs Tenet Healthcare Corporation — how do they compare? Shell PLC trades at $90.55 (market cap $245.77B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.93B). The key difference: Shell PLC is far larger — about 11.7× Tenet Healthcare Corporation's market cap, and Shell PLC pays a 3.47% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| SHEL | THC | |
|---|---|---|
Market Cap | $245.77B | $20.93B |
Sector | Energy | Health |
52-Week High | $94.15 | $262.63 |
52-Week Low | $70.31 | $161.37 |
Enterprise Value | $287.47B | $32.01B |
Dividend Yield | 3.47% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Shell (SHEL) trades at $88.50, down 1.23% today, with a bullish technical signal from moving averages and neutral oscillators. Recent earnings beat expectations in Q1 and Q2 2026, driven by higher oil prices and operational gains. The company maintains strong cash flow, reduced debt, and a discounted valuation with a P/E of 9.79. Analysts show strong buy sentiment, with a consensus price target of $103.60, and recent news highlights strategic asset sales and investments in gas projects.
Outlook is positive with earnings momentum and shareholder returns via dividends and buybacks, but risks include oil price volatility and regulatory pressures. The stock offers value with upside potential, though investors should monitor commodity swings and geopolitical factors affecting energy markets.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
